169 related articles for article (PubMed ID: 16709630)
21. Subunit arrangement and function in NMDA receptors.
Furukawa H; Singh SK; Mancusso R; Gouaux E
Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes.
Puddifoot CA; Chen PE; Schoepfer R; Wyllie DJ
Br J Pharmacol; 2009 Feb; 156(3):509-18. PubMed ID: 19154422
[TBL] [Abstract][Full Text] [Related]
23. Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors.
Anson LC; Chen PE; Wyllie DJ; Colquhoun D; Schoepfer R
J Neurosci; 1998 Jan; 18(2):581-9. PubMed ID: 9425000
[TBL] [Abstract][Full Text] [Related]
24. Mutations at F637 in the NMDA receptor NR2A subunit M3 domain influence agonist potency, ion channel gating and alcohol action.
Ren H; Salous AK; Paul JM; Lipsky RH; Peoples RW
Br J Pharmacol; 2007 Jul; 151(6):749-57. PubMed ID: 17519952
[TBL] [Abstract][Full Text] [Related]
25. The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.
Kenny AV; Cousins SL; Pinho L; Stephenson FA
J Biol Chem; 2009 Jan; 284(1):324-333. PubMed ID: 18990687
[TBL] [Abstract][Full Text] [Related]
26. Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.
Erreger K; Dravid SM; Banke TG; Wyllie DJ; Traynelis SF
J Physiol; 2005 Mar; 563(Pt 2):345-58. PubMed ID: 15649985
[TBL] [Abstract][Full Text] [Related]
27. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue.
Ronald KM; Mirshahi T; Woodward JJ
J Biol Chem; 2001 Nov; 276(48):44729-35. PubMed ID: 11572853
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors.
Dravid SM; Burger PB; Prakash A; Geballe MT; Yadav R; Le P; Vellano K; Snyder JP; Traynelis SF
J Neurosci; 2010 Feb; 30(7):2741-54. PubMed ID: 20164358
[TBL] [Abstract][Full Text] [Related]
29. Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
Yuan H; Hansen KB; Vance KM; Ogden KK; Traynelis SF
J Neurosci; 2009 Sep; 29(39):12045-58. PubMed ID: 19793963
[TBL] [Abstract][Full Text] [Related]
30. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
31. Kinetic contributions to gating by interactions unique to N-methyl-D-aspartate (NMDA) receptors.
Borschel WF; Cummings KA; Tindell LK; Popescu GK
J Biol Chem; 2015 Oct; 290(44):26846-55. PubMed ID: 26370091
[TBL] [Abstract][Full Text] [Related]
32. Mutations within the selectivity filter of the NMDA receptor-channel influence voltage dependent block by 5-hydroxytryptamine.
Kloda A; Adams DJ
Br J Pharmacol; 2006 Sep; 149(2):163-9. PubMed ID: 16894346
[TBL] [Abstract][Full Text] [Related]
33. Burst kinetics of single NMDA receptor currents in cell-attached patches from rat brain cortical neurons in culture.
Kleckner NW; Pallotta BS
J Physiol; 1995 Jul; 486 ( Pt 2)(Pt 2):411-26. PubMed ID: 7473207
[TBL] [Abstract][Full Text] [Related]
34. The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.
Yuan H; Vance KM; Junge CE; Geballe MT; Snyder JP; Hepler JR; Yepes M; Low CM; Traynelis SF
J Biol Chem; 2009 May; 284(19):12862-73. PubMed ID: 19240037
[TBL] [Abstract][Full Text] [Related]
35. Glutamate unbinding reveals new insights into NMDA receptor activation.
Gibb AJ
J Physiol; 2006 Jul; 574(Pt 2):329. PubMed ID: 16728444
[No Abstract] [Full Text] [Related]
36. Differential effects on current kinetics by point mutations in the lurcher motif of NR1/NR2A receptors.
Hu B; Zheng F
J Pharmacol Exp Ther; 2005 Mar; 312(3):899-904. PubMed ID: 15501991
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a tetrameric structure of recombinant NMDA receptors.
Laube B; Kuhse J; Betz H
J Neurosci; 1998 Apr; 18(8):2954-61. PubMed ID: 9526012
[TBL] [Abstract][Full Text] [Related]
38. NMDA receptors as targets of heavy metal interaction and toxicity.
Marchetti C; Gavazzo P
Neurotox Res; 2005 Nov; 8(3-4):245-58. PubMed ID: 16371319
[TBL] [Abstract][Full Text] [Related]
39. Site within N-Methyl-D-aspartate receptor pore modulates channel gating.
Chen N; Li B; Murphy TH; Raymond LA
Mol Pharmacol; 2004 Jan; 65(1):157-64. PubMed ID: 14722247
[TBL] [Abstract][Full Text] [Related]
40. Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating.
Sobolevsky AI; Prodromou ML; Yelshansky MV; Wollmuth LP
J Gen Physiol; 2007 Jun; 129(6):509-25. PubMed ID: 17504910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
